Pricing Log in Create free account

ABVC BioPharma, Inc. (ABVC) vs TransCode Therapeutics Inc. (RNAZ)

ABVC BioPharma, Inc. and TransCode Therapeutics Inc. are both Biotechnology companies. ABVC BioPharma, Inc. and TransCode Therapeutics Inc. are of similar size ($25.9M and $25.6M). Across the 9 metrics below, ABVC BioPharma, Inc. leads on 5 and TransCode Therapeutics Inc. on 4.

Valuation

Metric ABVC RNAZ Biotechnology median
P/E n/m n/m 10.60
P/S 19.38 n/m 9.40
P/B 2.06 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.11 0.66
EV/Sales 20.64 n/m 9.02
Earnings yield (35.01%) (3,354.19%) (32.88%)
Free cash flow yield (10.75%) (1,565.69%) (23.13%)

Profitability

Metric ABVC RNAZ Biotechnology median
Gross margin 99.97% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (65.32%) 429.61% (51.96%)
Return on assets (39.88%) (58.12%) (46.06%)
Return on invested capital (33.45%) 0.00% 0.00%

Growth

Metric ABVC RNAZ Biotechnology median
Revenue growth (TTM) 5,035.43% — 6.76%
EPS growth (last fiscal year) 7.14% 96.02% 29.88%
Revenue growth, 5-year CAGR (6.20%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABVC RNAZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.07 1.97 4.97
Net debt to EBITDA 0.21 0.64 1.01

Dividend

Metric ABVC RNAZ Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABVC RNAZ Biotechnology median
Market cap 25.92m 25.57m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack